Pharmasight
Sign inSee a worked packBook the bench
Ship · Medidata

Gained precedent-setting FDA approval for a hybrid synthetic control arm in a Phase 3 glioblastoma trial

MEDICENNAShipMedidata

Medidata is a Dassault Systèmes company supplying the clinical-trial EDC and data platform (Rave) most sponsors and CROs already run live trials on, now with an AI layer built in.

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.

Source

Published by Medidata on its own site — read the original case study on medidata.com ↗

More like this

Related use cases

  1. 01Data management transformation using Medidata's integrated product suite — (no dedicated case-study URL surfaced; featured on customer-testimonials pageCorcept TherapeuticsMedidataShip
  2. 02Strategic partnership to embed Medidata AI across the full trial lifecycleWorldwide Clinical TrialsMedidataShip
  3. 03Deployed Medidata Study Build AI (Designer) to accelerate global oncology pipelineMenarini GroupMedidataShip
  4. 04Replaced delayed site payments with Medidata Site Payments Managed ServicesCerevanceMedidataShip
  5. 05Streamlined oncology trials on the Medidata platform (video case studyAperioMedidataShip
  6. 06Used Rave EDC to improve patient screeningONCONOVAMedidataShip